Trial · NCT03278886
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Medication Tolerability Measured Via a 0-100 Visual Analog Scale | Low Dose Naltrexone | 90.7 | Standard Deviation 22.4 | score on a scale | |
| Medication Tolerability Measured Via a 0-100 Visual Analog Scale | Nalmefene | NA | Standard Deviation NA | score on a scale | |
| Change in Alcohol Use Defined as a Change in the Mean Number of Grams of Pure Ethanol Consumed Per Day From Baseline to 8 Weeks | Low Dose Naltrexone | 5.5 | Standard Deviation 10.1 | grams of ethanol | |
| Change in Alcohol Use Defined as a Change in the Mean Number of Grams of Pure Ethanol Consumed Per Day From Baseline to 8 Weeks | Nalmefene | -6.83 | Standard Deviation 9.7 | grams of ethanol | |
| Treatment Discontinuation Defined as Patient Self-report of Stopping Medication Anytime During the Treatment Period | Low Dose Naltrexone | 4-Weeks | 1 | treatment discontinuations | |
| Treatment Discontinuation Defined as Patient Self-report of Stopping Medication Anytime During the Treatment Period | Nalmefene | 4-Weeks | 1 | treatment discontinuations | |
| Treatment Discontinuation Defined as Patient Self-report of Stopping Medication Anytime During the Treatment Period | Low Dose Naltrexone | 8-Weeks | 1 | treatment discontinuations | |
| Treatment Discontinuation Defined as Patient Self-report of Stopping Medication Anytime During the Treatment Period | Nalmefene | 8-Weeks | 2 | treatment discontinuations | |
| Adherence to Medication Defined as Self-report of Percentage of Study Medication Taken in the Past Two Weeks | Low Dose Naltrexone | 87.5 | Standard Deviation 35.4 | score on a scale | |
| Adherence to Medication Defined as Self-report of Percentage of Study Medication Taken in the Past Two Weeks | Nalmefene | 0 | Standard Deviation 0 | score on a scale | |
| Number of Participants With Adherence Assessed Via Riboflavin in the Urine Confirming Adherence | Low Dose Naltrexone | 1 | participants | ||
| Number of Participants With Adherence Assessed Via Riboflavin in the Urine Confirming Adherence | Nalmefene | 0 | participants | ||
| Reported Side Effects Using a Symptom Checklist, Plus an Open-ended Question | Low Dose Naltrexone | 2-Weeks | 1.5 | Standard Deviation 1.6 | number of side effects |
| Reported Side Effects Using a Symptom Checklist, Plus an Open-ended Question | Nalmefene | 2-Weeks | 4.5 | Standard Deviation 6.4 | number of side effects |
| Reported Side Effects Using a Symptom Checklist, Plus an Open-ended Question | Low Dose Naltrexone | 4-Weeks | 1.3 | Standard Deviation 1.2 | number of side effects |
| Reported Side Effects Using a Symptom Checklist, Plus an Open-ended Question | Nalmefene | 4-Weeks | 1.5 | Standard Deviation 2.1 | number of side effects |
| Reported Side Effects Using a Symptom Checklist, Plus an Open-ended Question | Low Dose Naltrexone | 6-Weeks | 0.9 | Standard Deviation 1.0 | number of side effects |
| Reported Side Effects Using a Symptom Checklist, Plus an Open-ended Question | Nalmefene | 6-Weeks | 1.5 | Standard Deviation 2.1 | number of side effects |
| Reported Side Effects Using a Symptom Checklist, Plus an Open-ended Question | Low Dose Naltrexone | 8-Weeks | 0 | Standard Deviation 0 | number of side effects |
| Reported Side Effects Using a Symptom Checklist, Plus an Open-ended Question | Nalmefene | 8-Weeks | 0 | Standard Deviation 0 | number of side effects |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03278886/results